Clinical trial
Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and…
NCT00471614 · National Center for Complementary and Integrative Health (NCCIH), NIH · Completed
Key facts
| NCT number | NCT00471614 |
|---|---|
| Title | Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine |
| Official title | Uridine Supplementation, Mitochondrial Function, and Glucose Metabolism in HIV |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Insulin Resistance, Hyperlactatemia |
| Intervention type | Drug |
| Interventions | NucleomaxX (contains uridine) |
| Enrollment | 3 |
| Start date | Apr 1, 2007 |
| Primary completion | Jan 1, 2012 |
| Completion | Jan 1, 2012 |
| First posted | May 10, 2007 |
| Last update posted | May 16, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: